期刊
SEMINARS IN LIVER DISEASE
卷 27, 期 4, 页码 401-412出版社
THIEME MEDICAL PUBL INC
DOI: 10.1055/s-2007-991516
关键词
bile duct epithelium; ductopenia; primary biliary cirrhosis; primary sclerosing cholangitis; cholangiopathy
资金
- NIDDK NIH HHS [DK54208, DK062975] Funding Source: Medline
Cholangiopathies are characterized by a predominately bile duct-directed inflammatory response that leads to bile duct injury and, if the injury is persistent, bile duct loss and the chance of developing bile duct cancer (cholangiocarcinoma). Although the cholangiopathies have broad range of etiologies and pathogenesis (e.g., inherited disorders, autoimmune disorders, infections, drug-induced, ischemia, and unknown etiology), all share the common pathogenetic target-the biliary epithelial cell (cholangiocyte). For the most part, the pathogenesis of these diseases is poorly understood, which correspondingly has restricted clinicians to nonspecific and usually ineffective therapies for these disorders. Nevertheless, significant advances toward the understanding of the mechanisms involved in cholangiocyte-directed inflammation, biliary fibrosis, cholangiocyte death, and cholangiocarcinoma have unfolded over the past 15 years that may provide us new hopes and schemes for treatment of these disorders.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据